Remove Healthcare Remove Leads Remove Networking Remove Transportation
article thumbnail

How payers can use healthcare data to enhance network adequacy

Clarify Health

Designing and maintaining a healthcare network is no simple task—especially when it comes to meeting the needs for accessibility, quality, and cost across a diverse pool of members. Beyond supporting the health and well-being of its members, provider network adequacy is essential to a plan’s financial health and performance.

article thumbnail

Building a Robust Provider Network with SDoH Insights

Clarify Health

When building provider networks, it is crucial to include providers who can assess and address social determinants to ensure that care is equitable, patient-centered, and effective in improving health outcomes and reducing healthcare disparities.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.

article thumbnail

A Blueprint to Help Provider Networks Become Value-based Care Organizations in 2023

Clarify Health

Consider that transportation and other social determinant factors can be a roadblock to care for many patients. Now is the time to learn about VBC, population health, and how getting a grip on patient data can lead to better outcomes. Know how your organization is being measured.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.

article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Linked to talent, the presence of good universities is another great sign for life sciences, especially institutions with a focus on healthcare. Domestic market and transportation infrastructure. Industry clusters.

article thumbnail

Paragonix Technologies Receives FDA Clearance for BAROguard™ Donor Lung Preservation System

Legacy MEDSearch

Paragonix Technologies , a leading organ transplant company, received US Food and Drug Administration (“FDA”) clearance for its next-generation donor lung preservation system, BAROguard. Under current clinical practice, donor lungs are preserved and transported in an inflated state from donor to recipient site.

FDA 52